3,108
Views
41
CrossRef citations to date
0
Altmetric
Original Articles: Geriatric Oncology

Prognostic factors for the feasibility of chemotherapy and the Geriatric Prognostic Index (GPI) as risk profile for mortality before chemotherapy in the elderly

, , , , , , , & show all
Pages 15-23 | Received 20 Feb 2015, Accepted 24 Jun 2015, Published online: 14 Aug 2015

Figures & data

Table I. Baseline characteristics of 494 elderly cancer patients.

Table II. Results of the geriatric assessments of 494 elderly cancer patients.

Table III. Outcome of geriatric assessment of MNA (N = 490), GFI (N = 493), IQCODE (N = 480) and MMSE (N = 489) for feasibility of chemotherapy and overall mortality in elderly cancer patients.

Table IV. Independent effects of MNA and GFI items for feasibility of chemotherapy and overall mortality in 494 elderly cancer patients.

Table V. C-statistic coefficients of the different additional models for feasibility of chemotherapy and mortality.

Figure 1. Kaplan–Meier curves of overall survival in 494 elderly patients with various types of cancer according to: [A] MNA item A, [B] MNA item H, [C] GFI question 1 and [D] sum score of these three items.

Figure 1. Kaplan–Meier curves of overall survival in 494 elderly patients with various types of cancer according to: [A] MNA item A, [B] MNA item H, [C] GFI question 1 and [D] sum score of these three items.
Supplemental material

ionc_a_1068446_sm6238.zip

Download Zip (39 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.